(+)-Griseofulvin Good Manufacturer supply High Quality 126-07-8
- Molecular Formula:C17H17ClO6
- Molecular Weight:352.771
- Appearance/Colour:crystalline solid
- Vapor Pressure:3.11E-11mmHg at 25°C
- Melting Point:218-220 °C(lit.)
- Refractive Index:1.565
- Boiling Point:570.4 °C at 760 mmHg
- Flash Point:228 °C
- PSA：71.06000
- Density:1.38 g/cm3
- LogP:2.81030
(+)-Griseofulvin (126-07-8) Usage
Griseofulvin (126-07-8) is an antifungal antimitotic agent. Induces apoptosis of human germ cell tumor cells via disruption of connexin 43/tubulin association concomitant with enhanced translocation of connexin 43 from the cytoplasm to the nucleus.1?Inhibits the growth of adrenocortical cancer cells?in vitro.2 Griseofulvin inhibits centrosome clustering, induces spindle multipolarity, mitotic arrest and cell death in multiple tumor cell lines but not in diploid fibroblasts and keratinocytes with normal centrosome content.3
How to get the best price on (+)-Griseofulvin?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of (+)-Griseofulvin . You can buy high quality, low price (+)-Griseofulvin 126-07-8 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
